Characterising the scale-up and performance of antiretroviral therapy programmes in sub-Saharan Africa: an observational study using growth curves

被引:0
|
作者
Bigelow, Benjamin [1 ]
Verguet, Stephane [1 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Global Hlth & Populat, Boston, MA 02115 USA
来源
BMJ OPEN | 2020年 / 10卷 / 09期
关键词
public health; health policy; health economics; HIV & AIDS; MIDDLE-INCOME; HEALTH; MORTALITY; DECLINE; COUNTRIES; SYSTEMS;
D O I
10.1136/bmjopen-2019-034973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The rate of change in key health indicators (eg, intervention coverage) is an understudied area of health system performance. Rates of change in health services indicators can augment traditional measures that solely involve the absolute level of performance in those indicators. Growth curves are a class of mathematical models that can parameterise dynamic phenomena and estimate rates of change summarising these phenomena; however, they are not commonly used in global health. We sought to characterise the changes over time in antiretroviral therapy (ART) coverage in sub-Saharan Africa using growth curve models. Design This was a retrospective observational study. We used publicly available data on ART coverage levels from 2000 to 2017 in 42 sub-Saharan African countries. We developed two ordinary differential equations models, the Gompertz and logistic growth models, that allowed for the estimation of summary parameters related to scale-up and rates of change in ART coverage. We fitted non-linear regressions for the two models, assessed goodness of fit using the Bayesian information criterion (BIC), and ranked countries based on their estimated performance drawn from the fitted model parameters. Results We extracted country performance in rates of scale-up of ART coverage, which ranged from <= 2.5 percentage points per year (South Sudan, Sudan, and Madagascar) to >= 8.0 percentage points per year (Benin, Zimbabwe and Namibia), using the Gompertz model. Based on BIC, the Gompertz model provided a better fit than the logistic growth model for most countries studied. Conclusions Growth curve models can provide benchmarks to assess country performance in ART coverage evolution. They could be a useful approach that yields summary metrics for synthesising country performance in scaling up key health services.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Formative evaluation of antiretroviral therapy scale-up efficiency in sub-Saharan Africa
    Wagner, Glenn
    Ryan, Gery
    Taylor, Stephanie
    AIDS PATIENT CARE AND STDS, 2007, 21 (11) : 871 - 887
  • [2] Abandonment of antiretroviral therapy: A potential barrier to scale-up inn sub-Saharan Africa
    Reid, Stewart E.
    Mulenga, Lloyd B.
    Folk, William R.
    Tambatamba, Bushimbwa C.
    Chi, Benjamin H.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2008, 98 (06): : 448 - +
  • [3] Scale-up of antiretroviral therapy in sub-Saharan Africa - priorities for public health research
    Jaffar, Shabbar
    Mbidde, Edward
    Robb, Alistair
    Coutinho, Alex
    Muwanga, Moses
    Obermeyer, Carla Makhlouf
    Weller, Ian
    Hart, Graham
    Smith, Peter G.
    Haines, Andy
    Grosskurth, Heiner
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 (09) : 1009 - 1010
  • [4] Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes
    May, Margaret
    Boulle, Andrew
    Phiri, Sam
    Messou, Eugene
    Myer, Landon
    Wood, Robin
    Keiser, Olivia
    Sterne, Jonathan A. C.
    Dabis, Francois
    Egger, Matthias
    LANCET, 2010, 376 (9739): : 449 - 457
  • [5] Antiretroviral therapy in sub-Saharan Africa
    Müller, O
    Corrah, T
    Katabira, E
    Plummer, F
    Mabey, D
    LANCET, 1998, 351 (9095): : 68 - 68
  • [6] Delivery of antiretroviral therapy in sub-Saharan Africa
    Weller, Ian
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (06) : 777 - 778
  • [7] Challenges of scale-up to dolutegravir-based regimens in sub-Saharan Africa
    Salou, Mounerou
    Butel, Christelle
    Comlan, Adjo S.
    Konou, Abla A.
    Tegueni, Kokou
    Ehlan, Amivi
    Lack, Fiali
    Dossim, Sika
    Ayouba, Ahidjo
    Delaporte, Eric
    Dagnra, Anoumou Y.
    Peeters, Martine
    AIDS, 2020, 34 (05) : 783 - 787
  • [8] Determinants of antiretroviral therapy coverage in Sub-Saharan Africa
    Furuoka, Fumitaka
    Hoque, Mohammad Zahirul
    PEERJ, 2015, 3
  • [9] Antiretroviral therapy in sub-Saharan Africa: myth or reality?
    Kebba, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) : 747 - 749
  • [10] Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes
    Haas, Andreas D.
    Zaniewski, Elizabeth
    Anderegg, Nanina
    Ford, Nathan
    Fox, Matthew P.
    Vinikoor, Michael
    Dabis, Francois
    Nash, Denis
    Sinayobye, Jean d'Amour
    Niyongabo, Theodore
    Tanon, Aristophane
    Poda, Armel
    Adedimeji, Adebola A.
    Edmonds, Andrew
    Davies, Mary-Ann
    Egger, Matthias
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21